BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

84 related articles for article (PubMed ID: 22228583)

  • 21. Multiple cancer sites incidence rates estimation using a multivariate Bayesian model.
    Assunção RM; Castro MS
    Int J Epidemiol; 2004 Jun; 33(3):508-16. PubMed ID: 15044411
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Annual report to the nation on the status of cancer, 1975-2001, with a special feature regarding survival.
    Jemal A; Clegg LX; Ward E; Ries LA; Wu X; Jamison PM; Wingo PA; Howe HL; Anderson RN; Edwards BK
    Cancer; 2004 Jul; 101(1):3-27. PubMed ID: 15221985
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Lifetime earnings patterns, the distribution of future Social Security benefits, and the impact of pension reform.
    Bosworth B; Burtless G; Steuerle E
    Soc Secur Bull; 2000; 63(4):74-98. PubMed ID: 11641991
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Projections of HIV infections and AIDS cases to the year 2000.
    Chin J; Sato PA; Mann JM
    Bull World Health Organ; 1990; 68(1):1-11. PubMed ID: 2189583
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Evaluating heterogeneity in indoor and outdoor air pollution using land-use regression and constrained factor analysis.
    Levy JI; Clougherty JE; Baxter LK; Houseman EA; Paciorek CJ;
    Res Rep Health Eff Inst; 2010 Dec; (152):5-80; discussion 81-91. PubMed ID: 21409949
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Childhood cancer in the United States. A geographical analysis of cases from the Pediatric Cooperative Clinical Trials groups.
    Ross JA; Severson RK; Pollock BH; Robison LL
    Cancer; 1996 Jan; 77(1):201-7. PubMed ID: 8630931
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Estimates of long-term survival for newly diagnosed cancer patients: a projection approach.
    Mariotto AB; Wesley MN; Cronin KA; Johnson KA; Feuer EJ
    Cancer; 2006 May; 106(9):2039-50. PubMed ID: 16572414
    [TBL] [Abstract][Full Text] [Related]  

  • 28. NTP Toxicology and Carcinogenesis Studies of Coumarin (CAS No. 91-64-5) in F344/N Rats and B6C3F1 Mice (Gavage Studies).
    National Toxicology Program
    Natl Toxicol Program Tech Rep Ser; 1993 Sep; 422():1-340. PubMed ID: 12616289
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Prevalence of a history of skin cancer in 2007: results of an incidence-based model.
    Stern RS
    Arch Dermatol; 2010 Mar; 146(3):279-82. PubMed ID: 20231498
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Projections of cancer mortality risks using spatio-temporal P-spline models.
    Ugarte MD; Goicoa T; Etxeberria J; Militino AF
    Stat Methods Med Res; 2012 Oct; 21(5):545-60. PubMed ID: 22547690
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A mathematical estimation of true cancer incidence using data from population-based cancer registries.
    Kamo K; Kaneko S; Satoh K; Yanagihara H; Mizuno S; Sobue T
    Jpn J Clin Oncol; 2007 Feb; 37(2):150-5. PubMed ID: 17272318
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Adjustment of cancer incidence rates for ethnic misclassification.
    Stewart SL; Swallen KC; Glaser SL; Horn-Ross PL; West DW
    Biometrics; 1998 Jun; 54(2):774-81. PubMed ID: 9629656
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Time trend of mesothelioma incidence in the United States and projection of future cases: an update based on SEER data for 1973 through 2005.
    Price B; Ware A
    Crit Rev Toxicol; 2009; 39(7):576-88. PubMed ID: 19650718
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The American Cancer Society challenge goals. How far can cancer rates decline in the U.S. by the year 2015?
    Byers T; Mouchawar J; Marks J; Cady B; Lins N; Swanson GM; Bal DG; Eyre H
    Cancer; 1999 Aug; 86(4):715-27. PubMed ID: 10440701
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Predicting county-level cancer incidence rates and counts in the USA.
    Yu B
    Stat Med; 2013 Sep; 32(22):3911-25. PubMed ID: 23670947
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A modified Prevalence Incidence Analysis Model method may improve disease prevalence prediction.
    Novikov I; Olmer L; Keinan-Boker L; Silverman B; Robinson E; Freedman LS
    J Clin Epidemiol; 2020 Jul; 123():18-26. PubMed ID: 32201258
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A new method of predicting US and state-level cancer mortality counts for the current calendar year.
    Tiwari RC; Ghosh K; Jemal A; Hachey M; Ward E; Thun MJ; Feuer EJ
    CA Cancer J Clin; 2004; 54(1):30-40. PubMed ID: 14974762
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Validation of Canproj for projecting Canadian cancer incidence data.
    Demers A; Qiu Z; Dewar R; Shaw A
    Health Promot Chronic Dis Prev Can; 2020 Sep; 40(9):267-280. PubMed ID: 32909937
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A spatio-temporal autoregressive model for monitoring and predicting COVID infection rates.
    Congdon P
    J Geogr Syst; 2022; 24(4):583-610. PubMed ID: 35496370
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Temporal Aggregation Effects in Spatiotemporal Traffic Modelling.
    Pavlyuk D
    Sensors (Basel); 2020 Dec; 20(23):. PubMed ID: 33291588
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.